$108.85
0[0.00%]
At close: Apr 24
$108.85
0[0.00%]
PreMarket: 7:54PM EDT
Moderna
(NASDAQ:MRNA)Moderna Stock (NASDAQ:MRNA), Analyst Ratings, Price Targets, Predictions
Moderna Inc has a consensus price target of $141.28, established from looking at the 87 latest analyst ratings. The last 3 analyst ratings were released from Needham, Jefferies, and RBC Capital on April 11, 2024, April 9, 2024, and March 28, 2024. With an average price target of $83.33 between Needham, Jefferies, and RBC Capital, there's an implied -23.44% downside for Moderna Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Jefferies
RBC Capital
HSBC
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Moderna
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/11/2024 | MRNA | Buy Now | Moderna | $108.85 | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 04/09/2024 | MRNA | Buy Now | Moderna | $108.85 | 14.84% | Jefferies | Michael Yee | → $125 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | MRNA | Buy Now | Moderna | $108.85 | 14.84% | RBC Capital | Luca Issi | → $125 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | MRNA | Buy Now | Moderna | $108.85 | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 02/26/2024 | MRNA | Buy Now | Moderna | $108.85 | -20.99% | HSBC | Yifeng Liu | $75 → $86 | Downgrade | Hold → Reduce | Get Alert |
| 02/23/2024 | MRNA | Buy Now | Moderna | $108.85 | 14.84% | RBC Capital | Luca Issi | → $125 | Reiterates | Outperform → Outperform | Get Alert |
| 02/23/2024 | MRNA | Buy Now | Moderna | $108.85 | -16.4% | Canaccord Genuity | Bill Maughan | $82 → $91 | Maintains | Hold | Get Alert |
| 01/12/2024 | MRNA | Buy Now | Moderna | $108.85 | 14.84% | RBC Capital | Luca Issi | → $125 | Reiterates | Outperform → Outperform | Get Alert |
| 01/02/2024 | MRNA | Buy Now | Moderna | $108.85 | 30.45% | Oppenheimer | Hartaj Singh | → $142 | Upgrade | Perform → Outperform | Get Alert |
| 12/01/2023 | MRNA | Buy Now | Moderna | $108.85 | -17.32% | JP Morgan | Jessica Fye | $93 → $90 | Maintains | Neutral | Get Alert |
| 11/29/2023 | MRNA | Buy Now | Moderna | $108.85 | -24.67% | Canaccord Genuity | Bill Maughan | → $82 | Initiates | → Hold | Get Alert |
| 11/03/2023 | MRNA | Buy Now | Moderna | $108.85 | 14.84% | RBC Capital | Luca Issi | $180 → $125 | Maintains | Outperform | Get Alert |
| 11/03/2023 | MRNA | Buy Now | Moderna | $108.85 | 112.22% | Goldman Sachs | Salveen Richter | $269 → $231 | Maintains | Buy | Get Alert |
| 11/03/2023 | MRNA | Buy Now | Moderna | $108.85 | -36.61% | HSBC | Yifeng Liu | $89 → $69 | Upgrade | Reduce → Hold | Get Alert |
| 11/02/2023 | MRNA | Buy Now | Moderna | $108.85 | — | Deutsche Bank | Emmanuel Papadakis | — | Downgrade | Hold → Sell | Get Alert |
| 09/13/2023 | MRNA | Buy Now | Moderna | $108.85 | 28.62% | Argus Research | Jasper Hellweg | $160 → $140 | Maintains | Buy | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $108.85 | 13% | Morgan Stanley | Matthew Harrison | $128 → $123 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $108.85 | 37.8% | B of A Securities | Geoff Meacham | $175 → $150 | Maintains | Neutral | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $108.85 | 74.55% | RBC Capital | Luca Issi | $200 → $190 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Moderna (MRNA)?
The latest price target for Moderna (NASDAQ: MRNA) was reported by Needham on April 11, 2024. The analyst firm set a price target for $0.00 expecting MRNA to fall to within 12 months (a possible -100.00% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Moderna (MRNA)?
The latest analyst rating for Moderna (NASDAQ: MRNA) was provided by Needham, and Moderna reiterated their hold rating.
When was the last upgrade for Moderna (MRNA)?
The last upgrade for Moderna Inc happened on January 2, 2024 when Oppenheimer raised their price target to $142. Oppenheimer previously had a perform for Moderna Inc.
When was the last downgrade for Moderna (MRNA)?
The last downgrade for Moderna Inc happened on February 26, 2024 when HSBC changed their price target from $75 to $86 for Moderna Inc.
When is the next analyst rating going to be posted or updated for Moderna (MRNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
Is the Analyst Rating Moderna (MRNA) correct?
While ratings are subjective and will change, the latest Moderna (MRNA) rating was a reiterated with a price target of $0.00 to $0.00. The current price Moderna (MRNA) is trading at is $108.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.